AVICENNA RESEARCH
LIVE

Serial Number

98102260

Owner

Avicenna Research Inc.

Attorney

Matthew D. Delaney

Filing Date

Jul 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

AVICENNA RESEARCH Trademark

Serial Number: 98102260 • Registration: 8309742

AVICENNA RESEARCH is a trademark filed by Avicenna Research Inc. on July 26, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Avicenna Research Inc.

273 Lawrence Ave E
North York, Ontario M4N1T6 , CA

Entity Type: 03

Trademark Details

Filing Date

July 26, 2023

Registration Date

June 23, 2026

Published for Opposition

May 5, 2026

Goods & Services

Application service provider featuring application programming interface (API) software for analyzing molecular and clinical data for scientific and medical research; hosting an online community website for registered users to participate in discussions in the field of clinical trials and medical research; providing information on clinical studies via an interactive website; Software as a service (SaaS) services featuring software for clinical trial management; software as a service (SaaS) services featuring software for operating, managing, and administering clinical trials, recruiting patients, managing and monitoring data, capturing events, and reporting data; software as a service (SaaS) services featuring software for providing telemedicine services to patients; software as a service (SaaS) services featuring software for providing virtual healthcare services and healthcare consultations to patients; software as a service (SaaS) services featuring software for providing access to information on pharmaceuticals, clinical trials, and medical research; software as a service (SaaS) services featuring software for providing physician education, for accessing a healthcare application support tool used in providing delivery of medical treatments, and for accessing clinical decision support tools; software as a service (SaaS) services featuring software for patient engagement in clinical trials and when providing healthcare services; Creating an online community for registered users to participate in discussions, get feedback, form virtual communities, and engage in social networking in the field of clinical trials and medical research; Scientific research consulting services in the field of clinical trials, including design, planning, implementation, and project management of remote clinical trials utilizing mobile software applications; Application Service Provider (ASP) featuring software for hosting, managing, developing, analyzing, and maintaining applications, software, and websites in the fields of healthcare and healthcare research

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 23, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 23, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 29, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 12, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 31, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 31, 2025 GNSL
SUSPENSION LETTER WRITTEN
Oct 31, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2025 CRFA
ASSIGNED TO LIE
Oct 15, 2025 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Oct 6, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Aug 11, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Aug 11, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Aug 11, 2025 CNSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 10, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 12, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 12, 2024 GNSL
SUSPENSION LETTER WRITTEN
Aug 12, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2024 CRFA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
May 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
May 8, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 24, 2023 NWOS
NEW APPLICATION ENTERED
Jul 29, 2023 NWAP